Smith & Nephew’s Acquisition Of Orthopedic Joint Reconstruction Business Of Brainlab AG

Milbank LLP has advised the global medical technology company Smith & Nephew plc on the acquisition of the orthopedic joint reconstruction business of Brainlab AG and on entering into a long-term exclusive R&D cooperation agreement. The cooperation is intended to expand the company’s research and development activities, particularly in the areas of digital surgery and […]

Waypoint’s Takeover Of Stallergenes

Clifford Chance is advising the Special Committee of Directors of biopharmaceuticals group Stallergenes Greer (EPA: STAGR) in relation to the recommended acquisition of the company by its controlling shareholder Waypoint. The transaction, announced today, values the company at approximately €730 million. Waypoint currently owns approximately 84% of the company. Upon completion of the acquisition, which […]

Volkswagen Financial Services’ Acquisition Of Majority Stake In PTV Truckparking B.V.

Milbank LLP has advised PTV Planung Transport Verkehr AG on the sale of its majority stake in PTV Truckparking B.V. to Volkswagen Financial Services. Volkswagen Financial Services acquires 75.1 percent of the shares in the company and aims to strengthen its market position in the strategic parking business segment, increase synergies and further extend existing […]

Northleaf Stampede Infrastructure Partners’ Acquisition Of 100% Of Project Mula From Cobra Group

Clifford Chance has advised Cobra Group on the sale of 100% of Project Mula, a 493.655 MWp PV plant located in the region of Mula, Murcia (Spain), to Northleaf Stampede Infrastructure Partners and the drafting and negotiation of the engineering, procurement, construction contractual scheme. Once operational in June 2019, Mula will be the largest unsubsidised […]

Advanced Medical Solutions’s $25 Million Acquisition of Sealantis Limited

Goodwin advised Advanced Medical Solutions Group plc on the deal Advanced Medical Solutions Group plc (AIM: AMS) executed the acquisition of Sealantis Limited for $25 million (approximately £19 million) in cash with royalties due until December 2027 on sales of any of its products that are currently in development. Established in 1991, Advanced Medical Solutions […]